Answers are grounded in this paper and cite their sources.
Renal cell carcinoma • SFPQ/PSF-TFE3 renal cell carcinoma Symptoms: Hematuria • recurrent urinary tract infections • urinary urgency • weight loss Clinical Procedure: -Specialty: PathologyObjective: Rare disease Background:Transcription factor E3 (TFE3)-rearranged renal cell carcinoma is a rare subtype of renal tumor that relatively more frequent in the pediatric population.Histologically, it typically presents as a papillary neoplasm composed of clear epithelial cells with numerous psammoma bodies.Transcription factor EB (TFEB)-rearranged renal cell carcinoma is an even rarer entity, classically characterized by biphasic cellular morphology, rosette-like structures, and eosinophilic basement membrane-like material. Case Report:We describe a case of splicing factor proline-and glutamine-rich (SFPQ)/polypyrimidine tract-binding proteinassociated splicing factor (PSF)-TFE3 renal cell carcinoma confirmed by RNA sequencing that morphologically mimicked TFEB-rearranged renal cell carcinoma in a 66-year-old woman with concurrent high-grade urothelial carcinoma of the urinary bladder and ureter. Conclusions:This case expands the recognized histologic spectrum of TFE3-rearranged renal cell carcinoma and highlights the critical role of molecular testing in establishing a definitive diagnosis.
No takes yet. Share an insight, caveat, or question.
Zhou et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: